Skip to main content
All lobbying firms

THE MCMANUS GROUP

Registrant on federal lobbying filings · filed 2025 to 2026

$7,890,000 Income reported
31 Clients represented
165 Filings counted
0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. Everything on this page is grouped by the registrant's LDA id (286096), not by name.

 Clients 31
 Lobbyists named 1
  • JOHN MCMANUS 45 filings · through 2026 Staff Director, W&M Health Subcommittee. LA, Rep. Bill Thomas.

A lobbyist who previously held a covered government position must disclose it. We flag the ones whose name resolves to a member of Congress and link the ones still in our roster. The revolving door collects them across every firm.

 Reported by year 2 years
  • 2026 $2,640,000 52 filings
  • 2025 $5,250,000 113 filings
 Issues lobbied 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 5
  • HOUSE OF REPRESENTATIVES 152
  • SENATE 152
  • Centers For Medicare and Medicaid Services (CMS) 32
  • Health & Human Services, Dept of (HHS) 19
  • Office of Management & Budget (OMB) 15
 Recent filings 165 total
Q2
ZIMMER BIOMET
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $50,000 income · posted Jul 20, 2026
View →
Q2
WEX HEALTH
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $50,000 income · posted Jul 20, 2026
View →
Q2
VIVEX BIOLOGICS
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $50,000 income · posted Jul 20, 2026
View →
Q2
VIALASE INC.
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $50,000 income · posted Jul 20, 2026
View →
Q2
VENTURE MEDICAL
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $30,000 income · posted Jul 20, 2026
View →
Q2
ROCHE DIAGNOSTICS
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $40,000 income · posted Jul 20, 2026
View →
Q2
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $60,000 income · posted Jul 20, 2026
View →
Q2
OWLET
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $30,000 income · posted Jul 20, 2026
View →
Q2
NATIONAL ASSOCIATION OF FREESTANDING EMERGENCY CENTERS (NAFEC)
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $60,000 income · posted Jul 20, 2026
View →
Q2
MEDICAL DEVICE MANUFACTURERS ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $30,000 income · posted Jul 20, 2026
View →
Q2
LARGE UROLOGY GROUP PRACTICE ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $90,000 income · posted Jul 20, 2026
View →
Q2
INFUSION PROVIDERS ALLIANCE
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $90,000 income · posted Jul 20, 2026
View →
Q2
GRAIL, INC.
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $50,000 income · posted Jul 20, 2026
View →
Q2
GILEAD SCIENCES, INC.
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $60,000 income · posted Jul 20, 2026
View →
Q2
GENENTECH
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $50,000 income · posted Jul 20, 2026
View →
2T
FULCRUM THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $60,000 income · posted Jul 20, 2026
View →
Q2
DENDREON PHARMACEUTICALS LLC
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $30,000 income · posted Jul 20, 2026
View →
Q2
BRISTOL-MYERS SQUIBB
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $80,000 income · posted Jul 20, 2026
View →
Q2
BIOWOUND SOLUTIONS
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $50,000 income · posted Jul 20, 2026
View →
Q2
AMBULATORY SURGERY CENTER ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $60,000 income · posted Jul 20, 2026
View →

Showing the 20 most recent of 165 filings. Search the explorer for "THE MCMANUS GROUP".

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem